Dose dense, high intensity therapy in newly diagnosed elderly patients with acute myeloid leukemia using gemtuzumab ozogamicin (Mylotarg (TM)) and high dose cytarabine (HiDAC).
Rao, AV; Rizzieri, DA; Moore, JO; Decastro, C; Abernethy, AP; Jordan, M; Davis, P; Edmonds, E; Gockerman, JP
Volume / Issue
Start / End Page
International Standard Serial Number (ISSN)
46th Annual Meeting of the American-Society-of-Hematology
Conference Start Date
Conference End Date